This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
CAMBRIDGE, Mass., Feb. 9, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard Shea, Chief Financial Officer, and James Roach, M.D., Chief Medical Officer, will participate in a question and answer session at the Leerink Swann Hot Topics Roundtable Conference on Wednesday, February 16th at 10:15 am ET. Dr. Roach will also be participating in a panel on Emerging Platforms that will be held the same day at 10:45 am ET. The conference will be held in New York City.
A live audio webcast of the question and answer session will be available on the "Investors" section of the Company's website located at
www.momentapharma.com . A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available through June 20, 2011.
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs.
To receive additional information about Momenta, please visit the website at
www.momentapharma.com , which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.